Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

Vaccine
Christopher M ColemanMatthew Frieman

Abstract

Development of vaccination strategies for emerging pathogens are particularly challenging because of the sudden nature of their emergence and the long process needed for traditional vaccine development. Therefore, there is a need for development of a rapid method of vaccine development that can respond to emerging pathogens in a short time frame. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in late 2012 demonstrate the importance of coronaviruses as emerging pathogens. The spike glycoproteins of coronaviruses reside on the surface of the virion and are responsible for virus entry. The spike glycoprotein is the major immunodominant antigen of coronaviruses and has proven to be an excellent target for vaccine designs that seek to block coronavirus entry and promote antibody targeting of infected cells. Vaccination strategies for coronaviruses have involved live attenuated virus, recombinant viruses, non-replicative virus-like particles expressing coronavirus proteins or DNA plasmids expressing coronavirus genes. None of these strategies has progressed to an approved human coronavirus vaccine in the ten years since SARS-CoV emerged. He...Continue Reading

References

Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·K SimonsM J Gething
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Jul 8, 2003·The Journal of Pathology·Yanqing DingKaitai Yao
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Feb 1, 2005·Journal of Virology·L L M PoonJ S M Peiris
Sep 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Susanna K P LauKwok-Yung Yuen
Jan 16, 2007·PLoS Pathogens·Anjeanette RobertsKanta Subbarao
Feb 10, 2009·Nature Reviews. Microbiology·Lanying DuShibo Jiang
Apr 22, 2011·Expert Review of Vaccines·Karin Lövgren BengtssonAlbert Dme Osterhaus
Jul 21, 2012·Viruses·Sandrine BelouzardGary R Whittaker
Oct 19, 2012·The New England Journal of Medicine·Ali M ZakiRon A M Fouchier
Jul 24, 2013·Human Vaccines & Immunotherapeutics·Anne S De GrootWilliam Martin
Aug 8, 2013·Nature Medicine·Elizabeth Devitt

❮ Previous
Next ❯

Citations

Jul 18, 2014·Current Opinion in Infectious Diseases·Jaffar A Al-TawfiqZiad A Memish
Feb 19, 2016·Science Translational Medicine·Thomas LukeMatthew B Frieman
Apr 14, 2015·Expert Review of Vaccines·Amy B PapaneriJens H Kuhn
Sep 29, 2015·Expert Opinion on Biological Therapy·Lanying Du, Shibo Jiang
Feb 13, 2016·Nature Reviews. Drug Discovery·Alimuddin ZumlaKwok-Yung Yuen
Feb 11, 2016·Computational and Structural Biotechnology Journal·Jacinto López-SagasetaMatthew J Bottomley
Jan 23, 2016·Frontiers of Medicine·Mahmoud M ShehataGhazi Kayali
Mar 18, 2016·Expert Review of Vaccines·Lanying DuShibo Jiang
Jul 21, 2015·Antiviral Research·Neeltje van Doremalen, Vincent J Munster
Feb 7, 2015·Virus Research·Ian M Mackay, Katherine E Arden
Dec 3, 2014·Virus Research·Naru ZhangLanying Du
Jul 29, 2015·Nature Communications·Lingshu WangBarney S Graham
Apr 16, 2015·Human Vaccines & Immunotherapeutics·Jian TangYusen Zhou
Sep 30, 2014·Human Vaccines & Immunotherapeutics·Eva M Riedmann
Oct 28, 2016·Reviews in Medical Virology·Naif Khalaf Alharbi
Mar 24, 2017·Scientific Reports·Sawsan S Al-AmriAnwar M Hashem
Jan 26, 2017·Expert Opinion on Therapeutic Patents·Jiwon ChoiYoung Bong Kim
Mar 3, 2018·Viruses·Aasiyah Chafekar, Burtram C Fielding
Sep 1, 2017·Journal of Medical Microbiology·Ali A RabaanHatem M Alhani
Jul 31, 2018·Expert Review of Vaccines·Yusen ZhouLanying Du
Mar 27, 2015·Clinical Microbiology Reviews·Jasper F W ChanKwok-Yung Yuen
Aug 29, 2017·Human Vaccines & Immunotherapeutics·Joel N Maslow
Jan 26, 2020·Journal of Medical Virology·Geng LiJianguo Wu
Apr 3, 2020·Vaccines·Jinyong ZhangQuanming Zou
Mar 27, 2020·Current Topics in Medicinal Chemistry·Prasad MinakshiGaya Prasad
Aug 1, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daniel P Otto, Melgardt M de Villiers
Jan 20, 2019·Viruses·Craig Schindewolf, Vineet D Menachery
Feb 9, 2019·Frontiers in Immunology·Soultan Al-HalifaDenis Archambault
Apr 25, 2020·Infectious Diseases and Therapy·Eriko Padron-Regalado
Aug 13, 2020·Macromolecular Bioscience·Wali MuhammadChangyou Gao
Oct 20, 2017·Human Vaccines & Immunotherapeutics·Heeyoun ChoIn-Kyu Yoon
Jun 7, 2019·Emerging Microbes & Infections·Jiuyang XuLinqi Zhang
Aug 21, 2019·Frontiers in Microbiology·Chean Yeah YongWen Siang Tan

❮ Previous
Next ❯

Datasets Mentioned

BETA
AGN70962
AAP13441

Methods Mentioned

BETA
size exclusion chromatography
dynamic light scattering
column chromatography
electron microscopy

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.